IND Swift Laboratories

IND Swift Laboratories Equity

The The Equity of IND Swift Laboratories (INDSWFTLAB.NS) as of Oct 22, 2026 is 13.84 B INR. In the previous year, The Equity was 11.73 B INR — a change of 17.99% (higher).

Equity

13.84 BINR

YoY

17.99%

Last updated:

In 2026, IND Swift Laboratories's equity was 13.84 B INR, a 17.99% increase from the 11.73 B INR equity in the previous year.

The IND Swift Laboratories Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
6.04 B INR
Jan 1, 2020
6.41 B INR
Jan 1, 2021
6.04 B INR
Jan 1, 2022
6.01 B INR
Jan 1, 2023
6.82 B INR
Jan 1, 2024
9.36 B INR
Jan 1, 2025
11.73 B INR
Jan 1, 2026
13.84 B INR
The IND Swift Laboratories Equity history
YEAREquityYoY
13.84 BINR+17.99%
11.73 BINR+25.30%
9.36 BINR+37.28%
6.82 BINR+13.47%
6.01 BINR-0.42%
6.04 BINR-5.80%
6.41 BINR+6.08%
6.04 BINR+9.16%
5.53 BINR+4.13%
5.31 BINR+2.69%
5.17 BINR-14.63%
6.06 BINR-16.43%
7.25 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

IND Swift Laboratories Stock analysis

What does IND Swift Laboratories do? IND Swift Laboratories is one of the most popular companies on Eulerpool.

Equity Details

Analyzing IND Swift Laboratories's Equity

IND Swift Laboratories's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding IND Swift Laboratories's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating IND Swift Laboratories's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

IND Swift Laboratories's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in IND Swift Laboratories’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about IND Swift Laboratories stock

The Equity of IND Swift Laboratories is 13.84 B INR in 2026.

The Equity of IND Swift Laboratories changed from 11.73 B INR to 13.84 B INR, representing a 17.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity IND Swift Laboratories since 2006 – with annual values, charts, and detailed analysis.

The Equity's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's IND Swift Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — IND Swift Laboratories

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — IND Swift Laboratories